Adrian Butash New EVP & Marketing Director for Applied DNA Sciences.

LOS ANGELES -- Adrian Butash has been appointed Executive Vice President and Chief Marketing Officer of Applied DNA Sciences, Inc. (OTCBB:APDN), Peter Brocklesby, the company's president, announced today. APDN's proprietary DNA solutions include DNA security elements embedded in inks, paper, plastics, liquids, and microchips. The products prevent counterfeiting and product diversion.

"Adrian Butash is an experienced marketing professional, with blue-chip creative, marketing and product branding credentials," Brocklesby said. "He brings a high level of dynamic thinking to the company to position it in the forefront of the global security and brand protection business. Butash's wealth of experience, especially in the fashion, cosmetics, fragrances, and pharmaceutical industries, all of which are prime targets for counterfeiting, is of critical importance to APDN." Butash's global marketing responsibilities include sales, strategic business development, advertising, public relations, and investor relations.

"I believe the company's Bio DNA-microchip, the world's first bio-digital microchip, will be the definitive security product of the future," Butash said. "For U.S. and foreign corporations, APDN's patented DNA technology is the ultimate security system to prevent product counterfeiting, to ensure brand protection, and to protect a corporation's global supply chain. DNA security has elicited great interest among U.S. and foreign government security agencies."

Butash's career encompasses Fortune 100 consumer and retail marketing; advertising and branding in fashion, cosmetics, and fragrance; publishing; medical; and retailing. For 20 years, his NYC marketing/advertising agency, Adrian, Inc., had clients that included Time Magazine, Brentano's Bookstores, Foster Grant, Sea & Ski, Takasago, Cooper Vision, Cooper Pharmaceutical, Elizabeth Arden, John Weitz, Oxford Industries, and Brown Shoe Corporation's Etage Stores.

Butash was a marketing executive with Celanese Corporation and Hoechst Fibers Inc., where he created many high-visibility programs for the fashion/retail industry, including pioneering the "printacular" -- multi-page fashion magazine advertising sections. His 103-page section for Celanese Fibers, which ran in the 100th anniversary issue of Harper's Bazaar, remains the largest fashion advertising section ever published. Butash created and produced the nationally syndicated women's daytime talk show "Living Easy," hosted by Dr. Joyce Brothers. He produced the award-winning fashion film "Man in The Trevira Era," and "Levi's in America," a fine-art portfolio for Levi Strauss, and won a coveted Fragrance Foundation Advertising Award for his "We Are the Music" campaign for Takasago fragrances. Butash was an executive vice president of M. Knoedler & Co. gallery, and was the owner/publisher of American Fabrics & Fashions Magazine. A color expert, Butash is a director of The Color Association of the United States, and is a graduate of Fordham University.

About Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. provides proprietary, DNA-embedded security solutions, using plant (non-human) DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft, and unauthorized intrusion. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan, whose technology is protected by 10 international patents (http://www.biowell.com.tw/eng). Applied DNA Sciences, Inc., 9229 West Sunset Boulevard, Los Angeles, CA 90069; Tel: [phone]; Fax: [phone]; www.ADNAS.com.

Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the Company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks detailed in the Company's Registration Statement filed with the SEC.